DE69110060D1 - In der humantherapie nützliche substanzen peptidischer natur. - Google Patents

In der humantherapie nützliche substanzen peptidischer natur.

Info

Publication number
DE69110060D1
DE69110060D1 DE69110060T DE69110060T DE69110060D1 DE 69110060 D1 DE69110060 D1 DE 69110060D1 DE 69110060 T DE69110060 T DE 69110060T DE 69110060 T DE69110060 T DE 69110060T DE 69110060 D1 DE69110060 D1 DE 69110060D1
Authority
DE
Germany
Prior art keywords
substances
administered
human therapy
peptidic nature
nature useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110060T
Other languages
English (en)
Other versions
DE69110060T2 (de
Inventor
Alberto Bartorelli
Angela Turiano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetesis SpA
Original Assignee
Zetesis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis SpA filed Critical Zetesis SpA
Publication of DE69110060D1 publication Critical patent/DE69110060D1/de
Application granted granted Critical
Publication of DE69110060T2 publication Critical patent/DE69110060T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69110060T 1990-12-11 1991-12-09 In der humantherapie nützliche substanzen peptidischer natur. Expired - Fee Related DE69110060T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy

Publications (2)

Publication Number Publication Date
DE69110060D1 true DE69110060D1 (de) 1995-06-29
DE69110060T2 DE69110060T2 (de) 1995-09-28

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69110060T Expired - Fee Related DE69110060T2 (de) 1990-12-11 1991-12-09 In der humantherapie nützliche substanzen peptidischer natur.

Country Status (16)

Country Link
US (1) US5824640A (de)
EP (1) EP0574394B1 (de)
JP (1) JP3213942B2 (de)
KR (1) KR100196028B1 (de)
AT (1) ATE122890T1 (de)
AU (1) AU661287B2 (de)
CA (1) CA2098113C (de)
CZ (1) CZ283037B6 (de)
DE (1) DE69110060T2 (de)
DK (1) DK0574394T3 (de)
ES (1) ES2073277T3 (de)
HU (1) HU217615B (de)
IT (1) IT1244879B (de)
NO (1) NO308396B1 (de)
RU (1) RU2113224C1 (de)
WO (1) WO1992010197A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
ES2192669T3 (es) 1996-09-18 2003-10-16 Zetesis Spa Uso de proteinas como agentes frente a enfermedades autoinmunes.
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
WO2001093894A2 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of parkinson's disease with a protein extractable from mammalian organs
AU2001278436A1 (en) 2000-06-08 2001-12-17 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
JPH075476B2 (ja) * 1984-01-12 1995-01-25 ルッシュ、フォルケル ホルモン活性を有する生物学的作用物質、その製法およびヒストンの医薬的用途
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
ES2073277T3 (es) 1995-08-01
RU2113224C1 (ru) 1998-06-20
IT9022341A1 (it) 1992-06-11
HU9301677D0 (en) 1993-09-28
NO932101D0 (no) 1993-06-09
CA2098113C (en) 2002-02-05
DE69110060T2 (de) 1995-09-28
CZ111693A3 (en) 1994-04-13
WO1992010197A1 (en) 1992-06-25
CZ283037B6 (cs) 1997-12-17
AU9035791A (en) 1992-07-08
IT1244879B (it) 1994-09-12
NO308396B1 (no) 2000-09-11
DK0574394T3 (da) 1995-10-16
ATE122890T1 (de) 1995-06-15
US5824640A (en) 1998-10-20
IT9022341A0 (it) 1990-12-11
EP0574394A1 (de) 1993-12-22
KR100196028B1 (ko) 1999-06-15
NO932101L (no) 1993-08-10
HU217615B (hu) 2000-03-28
AU661287B2 (en) 1995-07-20
EP0574394B1 (de) 1995-05-24
JPH06504039A (ja) 1994-05-12
JP3213942B2 (ja) 2001-10-02
CA2098113A1 (en) 1992-06-11
HUT64569A (en) 1994-01-28

Similar Documents

Publication Publication Date Title
DE69110060D1 (de) In der humantherapie nützliche substanzen peptidischer natur.
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
DK0584266T3 (da) Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
RU95110767A (ru) Днк, кодирующая гликопротеин человеческого происхождения
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
GR1000477B (el) Νεο μονοκλωνικο αντισωμα κατα νεου αντιγονου που σχετιζεται με ανθρωπινους ογκους.
DE69034135D1 (de) DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
NL990034I1 (nl) DNA dat codeert voor humane tumor necrosis faktor en humane tumor necrosis faktor polypeptide.
TR199800607T1 (xx) Dendritik h�cre uyar�c� fakt�r�.
NZ309659A (en) Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses
IT8148663A0 (it) Linea di cellule derivate da epato ma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
IT1298487B1 (it) Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
ATE309382T1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
CA2078773A1 (en) Gp75 as a tumor vaccine for melanoma
ATE214101T1 (de) Expression von heterologen genen in menschlichen brustzellen, einschliesslich menschliche brustkarzionomzellen unter der kontrolle von regulatorischen sequenzen von wap oder mmtv
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
ES8600518A1 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
EP0136093A3 (de) Antikrebsfaktoren
ATE463566T1 (de) Tumor- und seneszenzsmarker
SU1077090A1 (ru) Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека
DE68911305D1 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee